Recent Advances in in Vivo Metabolism and in Vitro Synthesis of Breast Milk Oligosaccharides

被引:1
作者
Chen Q. [1 ]
Shi F. [1 ]
Zhao L. [1 ]
Liang S. [1 ]
Masumuzzanm M.D. [1 ]
Huo G. [1 ]
Li B. [1 ]
机构
[1] Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin
来源
Shipin Kexue/Food Science | 2021年 / 42卷 / 19期
关键词
Current applications; Human milk oligosaccharides; Metabolism; Probiotics; Structural diversity; Synthesis;
D O I
10.7506/spkx1002-6630-20200925-315
中图分类号
学科分类号
摘要
Human milk oligosaccharides (HMOs) are unique nutrients in breast milk, which have complex and multifarious structures. Different HMOs may have different functions. In this article, we summarize the latest progress in understanding the individual difference, structural diversity and functional activity of HMOs. We put a special focus on the metabolic pathway in human body and the synthetic pathway in vitro of HMOs. Finally, we discuss the current status of the application of HMOs in infant formula and problems facing HMOs research and application. The application of HMOs in infant formula is a major breakthrough and it has great potential in narrowing the gap between formula-fed infants and breast-fed infants in intestinal flora composition, immune function and cognition capacity. In-depth studies of HMOs will offer the theoretical basis for the developement of new infant formula. © 2021, China Food Publishing Company. All right reserved.
引用
收藏
页码:379 / 387
页数:8
相关论文
共 62 条
  • [21] (2012)
  • [22] DONOVAN S M, COMSTOCK S S., Human milk oligosaccharides influence neonatal mucosal and systemic immunity, Annals of Nutrition and Metabolism, 69, 2, pp. 42-51, (2016)
  • [23] KULINICH A, LIU L., Human milk oligosaccharides: the role in the fine-tuning of innate immune responses, Carbohydrate Research, 432, 1, pp. 62-70, (2016)
  • [24] SOTGIU S, ARRU G, FOIS M L, Et al., Immunomodulation of fucosyllactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects, International Journal of Biomedical Science, 2, 2, pp. 114-120, (2006)
  • [25] ZHU B, TRIKUDANATHAN S, ZOZULYA A L, Et al., Immune modulation by lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis, Clinical Immunology, 142, 3, pp. 351-361, (2012)
  • [26] BODE L, JANTSCHERKRENN E., Structure-function relationships of human milk oligosaccharides, Advances in Nutrition, 3, 3, pp. 383S-391S, (2012)
  • [27] ZENHOM M, HYDER A, DE VRESE M, Et al., Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3, Journal of Nutrition, 141, 5, pp. 971-977, (2011)
  • [28] EIWEGGER T, STAHL B, SCHMITT J, Et al., Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro, Pediatric Research, 56, 4, pp. 536-540, (2004)
  • [29] HE Y, LIU S, LEONE S, Et al., Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine, Mucosal Immunology, 7, 6, pp. 1326-1339, (2014)
  • [30] COLLINS B E, PAULSON J C., Cell surface biology mediated by low affinity multivalent protein-glycan interactions, Current Opinion in Chemical Biology, 8, 6, pp. 617-625, (2004)